Table 1 Baseline clinical characteristics of the study population

From: Impact of antihypertensive treatment on left ventricular systolic dyssynchrony in treatment-naïve hypertensive patients

 

HT with LV systolic dyssynchrony (Group 1, n=29)

HT without LV systolic dyssynchrony (Group 2, n=31)

P-values

Age (years)

53±9

55±10

0.439

Male gender, n (%)

13 (44.8)

19 (61.3)

0.154

Body mass index (kg m−2)

26.0±2.8

25.0±3.2

0.175

SBP (mm Hg) at office

162±17

157±17

0.264

DBP (mm Hg) at office

98±14

96±11

0.521

QRS duration (ms)

85±15

86±13

0.886

Heart rate (beats per minute)

68±8

69±10

0.711

Fasting plasma glucose (mg dl−1)

110±11

108±12

0.905

Hyperlipidemia, n (%)

13 (44.8)

22 (71.0)

0.040

Metabolic syndrome, n (%)

15 (51.7)

18 (41.9)

0.448

Estimated GFR by MDRD formula (ml min−1 per 1.73 m2)

84.5±16.6

81.5±11.7

0.413

Current smoker, n (%)

3 (10.3)

12 (38.7)

0.011

Hs-CRP (mg dl−1)

0.22±0.20

0.23±0.18

0.786

  1. Abbreviations: DBP, diastolic blood pressure; GFR, glomerular filtration rate; Hs-CRP, high-sensitive C-reactive protein; HT, hypertension; LV, left ventricular; MDRD, Modification of Diet in Renal Disease Study Group; n, number; SBP, systolic blood pressure.
  2. Values are arithmetic mean±s.d.
Back to article page